Vigeo

Q: What is Vigeo's official website?

Vigeo's official website is www.vigeotx.com

Q: What industry does Vigeo belong to?

Vigeo is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is Vigeo competition?

Vigeo top competitors include: Ethan Hughes Lab , Agile , Tuckerman Terraces , Tellbio

Q: What technology does Vigeo use?

Some of the popular technologies that Vigeo uses are: WordPress.org, PHP, Google Font API, jQuery Migrate

Q: How do I contact Vigeo?

Vigeo contact info: Phone number: (617) 279-0589 Website: www.vigeotx.com

Q: What does Vigeo do?

Vigeo Therapeutics is a clinical-stage biopharmaceutical company headquartered in Cambridge, MA. The company develops a drug development pipeline aimed at reinvigorating the immune system to combat cancer and inflammatory diseases. Its approach focuses on developing therapies that activate the production of TSP-1, a naturally occurring immune syste... m regulatory protein designed to attack cancer cells and reduce inflammation at the cellular level. Vigeo serves patients with multiple types of cancer, including those with glioblastoma, and delivers its value through the development of novel therapeutics and clinical trials. Read More

Q: What are Vigeo social media links?

Vigeo Linkedin page Vigeo Twitter page

Q: Is Vigeo a public company?

Vigeo is private company therefore does not currently have an official ticker symbol

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

85 Bolton St Ste 233, Cambridge, Massach...

Phone Number

(617) 279-0589

Website

www.vigeotx.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Vigeo

Vigeo Therapeutics is a clinical-stage biopharmaceutical company headquartered in Cambridge, MA. The company develops a drug development pipeline aimed at reinvigorating the immune system to combat cancer and inflammatory diseases. Its approach focuses on developing therapies that activate the production of TSP-1, a naturally occurring immune system regulatory protein designed to attack cancer cells and reduce inflammation at the cellular level. Vigeo serves patients with multiple types of cancer, including those with glioblastoma, and delivers its value through the development of novel therapeutics and clinical trials.Explore more

Is this data correct?

View contact profiles from Vigeo

SIC Code 28,283NAICS Code 32,325Show more

Vigeo Org Chart

Phone

Judy Chiao

Senior VP, Clinical Development

Phone

Vice President, Clinical Regulatory Operation...

Phone

Vice President & Operations Head of Project M...

Phone

Get the full picture

Compare Similar Companies to Vigeo

Compare insights from companies similar to Vigeo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.